سعر ريسفيوتال 5مجم 7 اقراص 2022

Risefutal 5 mg risedronate sodium 5 mg film-coated tablets by Future Pharmaceutical Industries (FPI), pack of 7.

• Treatment and prevention of postmenopausal osteoporosisPopulation: Postmenopausal womenDailyMed (U.S. National Library of Medicine)
• Treatment and prevention of glucocorticoid-induced osteoporosisPopulation: Men and women on >=7.5 mg/day prednisone equivalentDailyMed (U.S. National Library of Medicine)

• In daily 5 mg trials, serious adverse events and withdrawals were similar to placebo; upper GI adverse reactions, musculoskeletal pain and hypocalcaemia are described in the label.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Oesophageal abnormalities delaying emptying (stricture, achalasia); inability to stand or sit upright for 30 minutes; hypocalcaemia; hypersensitivity to risedronate or excipients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Upper gastrointestinal irritation (oesophagitis, ulcers, erosions); use caution with active upper GI disease.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Correct hypocalcaemia before therapy; ensure adequate calcium and vitamin D. Osteonecrosis of the jaw, severe musculoskeletal pain and atypical femoral fractures have been reported. Do not combine with other risedronate products (e.g. Atelvia).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Calcium, antacids, magnesium, iron and other polyvalent cation productsInterfere with absorption of risedronate; take at a different time of day.DailyMed (U.S. National Library of Medicine)

• Human data insufficient to inform drug-associated risk; discontinue when pregnancy is recognized; animal studies showed decreased neonatal survival, cleft palate and delayed ossification.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Risedronate sodium: Binds hydroxyapatite in bone and acts as an antiresorptive agent by inhibiting osteoclasts, reducing bone turnover and resorption (US Actonel label).